E-LIB Suche - Ergebnisse für: Walder, A.

1

Experiences and developments of the RAL-LCG2 Tier-1 object ..:

Walder, J. ; Byrne, T. ; Dewhurst, A....
EPJ Web of Conferences. 295 (2024) - p. 01019 , 2024

Link: https://doi.org/10.1051/..

2

SA39 Targeted Treatments for Patients with Relapsed and/or ..:

Mohseninejad, L. ; Walder, L. ; Ubi, S....
Value in Health. 26 (2023) 12 - p. S548-S549 , 2023

Link: https://doi.org/10.1016/..

3

EE667 Cost-Minimization Analysis (CMA) of Bruton Tyrosine K..:

Chanan-Khan, A. ; Mohseninejad, L. ; Walder, L....
Value in Health. 26 (2023) 12 - p. S182 , 2023

Link: https://doi.org/10.1016/..

4

The Predictive Value of the G8 Questionnaire in Older Patie..:

Wu, X. ; Kumar, R. ; Milner-Watts, C....
Clinical Oncology. 35 (2023) 2 - p. e163-e172 , 2023

Link: https://doi.org/10.1016/..

5

SA23 Bruton Tyrosine Kinase Inhibitor (BTKi) Monotherapy fo..:

Mohseninejad, L. ; Walder, L. ; Ubi, S....
Value in Health. 26 (2023) 12 - p. S545 , 2023

Link: https://doi.org/10.1016/..

6

RWD38 Genetic Mutational Testing in CLL Patients in the Rou..:

Walder, A ; Csanádi, M ; Pitter, JG...
Value in Health. 25 (2022) 12 - p. S455 , 2022

Link: https://doi.org/10.1016/..

7

Toxic iron species in lower-risk myelodysplastic syndrome p..:

Hoeks, Marlijn ; Bagguley, Tim ; van Marrewijk, Corine...
Leukemia. 35 (2020) 6 - p. 1745-1750 , 2020

Link: https://doi.org/10.1038/..

8

Reliability Characterization for 12 V Application Using the..:

, In: 2020 IEEE International Reliability Physics Symposium (IRPS),

Su, C.-Y. ; Armstrong, M. ; Chugh, S.... - p. 1-5 , 2020

Link: https://doi.org/10.1109/..

9

Time without symptoms or toxicity in patients with recurren..:

Matulonis, U.A. ; Walder, L. ; Nøttrup, T.J....
Gynecologic Oncology. 154 (2019) - p. 2 , 2019

Link: https://doi.org/10.1016/..

10

Evaluation of mdt-tongue tie service provided at homerton u..:

Blanchard, J. ; Palmer, J. ; Walder, J...
International Journal of Oral and Maxillofacial Surgery. 48 (2019) - p. 246 , 2019

Link: https://doi.org/10.1016/..

11

PCN342 THE UPTAKE AND IMPACT OF THE EQ-5D-5L VALUE SET IN N..:

Walder, L. ; Hansen-Maughan, J. ; Oddsdottir, J..
Value in Health. 22 (2019) - p. S502-S503 , 2019

Link: https://doi.org/10.1016/..

12

PMD106 - COST-EFFECTIVENESS OF LONG-LASTING INSECTICIDE-NET..:

Walder, L. ; Fisher, M.
Value in Health. 21 (2018) - p. S261 , 2018

Link: https://doi.org/10.1016/..

13

Cost-Effectiveness of Niraparib Versus Routine Surveillance..:

Fisher, M ; Guy, H ; Walder, L
Value in Health. 21 (2018) - p. S32 , 2018

Link: https://doi.org/10.1016/..

14

PCN39 - ESTIMATING THE MEAN PROGRESSION-FREE SURVIVAL OF NI..:

Fisher, M. ; Guy, H. ; Walder, L.
Value in Health. 21 (2018) - p. S21 , 2018

Link: https://doi.org/10.1016/..

15

PCN7 - A TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF NIRA..:

Mirza, M.R. ; Walder, L. ; Monk, B.J....
Value in Health. 21 (2018) - p. S16 , 2018

Link: https://doi.org/10.1016/..